Studies on mechanisms of calcium channel modulators

https://doi.org/10.1016/S0022-2828(87)80004-4Get rights and content

First page preview

First page preview
Click to open first page preview

References (56)

  • WilliamsJ.S. et al.

    Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: Receptor binding, electrophysiological, and pharmacological studies

    Biochem Biophys Res Commun

    (1985)
  • YamamotoH. et al.

    Bay k 8644 differentiates between potential and receptor operated Ca2+ channels

    Eur J Pharmacol

    (1984)
  • ArmstrongC.M. et al.

    Two distinct populations of calcium channels in a clonal line of pituitary cells

    Science

    (1985)
  • BeanB.P.

    Nitrendipine block of cardiac calcium channels: High affinity binding to the inactivated state

    Proc Natl Acad Sci USA

    (1984)
  • BeanB.P.

    Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology

    J Gen Physiol

    (1985)
  • CognardC. et al.

    Different types of Ca2+ channels in mammalian skeletal muscle cell in culture

    Proc Natl Acad Sci USA

    (1986)
  • CognardC. et al.

    Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay k 8644) and inhibitor (PN200-110)

    Proc Natl Acad Sci USA

    (1986)
  • CurtisB.M. et al.

    Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules

    Biochemistry

    (1984)
  • DubeG.P. et al.

    Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: Biphasic mechanical response and paradoxicalpotentiation of contraction by diltiazem and nimodipine

    J Cardiovasc Pharmacol

    (1985)
  • EllrodtA.G. et al.

    Clinical applications of slow channel blocking compounds

    Pharmac Ther

    (1983)
  • FleckensteinA.

    Calcium Antagonism: History and prospects for a multifaceted pharmacological principle

  • FleckensteinA.

    History of calcium antagonists

    Circ Res

    (1983)
  • FriedmanM. et al.

    Two calcium currents in a smooth muscle cell line

    Am J Physiol

    (1986)
  • GelmersH.J.

    Nimodipine, a new calcium antagonist in the prophylactic treatment of migraine

    Headache

    (1983)
  • GibsonR.S. et al.

    Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

    New Engl J Med

    (1986)
  • GlossmannH. et al.

    Calcium channels: Basic properties as revealed by radioligand binding studies

    J Cardiovasc Pharmacol

    (1985)
  • GlossmannH. et al.

    Calcium channels and calcium channel drugs: Recent biochemical and biophysical findings

    Arnzheim-Forsch/Drug Res

    (1985)
  • HessP. et al.

    Different modes of Ca channel gating behavior favoured by dihydropyridine Ca agonists and antagonists

    Nature

    (1984)
  • Cited by (19)

    • S- and C-nucleosidoquinazoline as new nucleoside analogs with potential analgesic and anti-inflammatory activity

      2009, European Journal of Medicinal Chemistry
      Citation Excerpt :

      Adult male Sprague-Dawley rats, weighing 150–200 g were used for anti-inflammatory and ulcerogenic activity, whereas Swiss albino mice of both sex weighing 25–30 g were used for analgesic activity. International principles and local regulations concerning the care and used of laboratory animals were taken into account [17]. The animals had free access to standard commercial diet and water adlibitum and were kept in rooms maintained at 22 ± 1 °C with 12 h light dark cycle.

    • Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings

      2009, European Journal of Medicinal Chemistry
      Citation Excerpt :

      The pharmacodynamic versatility of 4-quinazolinone moiety has been documented not only in many of its synthetic derivatives but also in several naturally occurring alkaloids isolated from animals, families of plant kingdoms and from microorganism [1–3]. These isolated quinazolinones derivatives were found to have wide range of biological properties including anti-tumour, sedative, analgesic, antidiabetic, antibacterial, anti-inflammatory, antifungal and anticancer [4–10]. In addition, characterization of potential N-methyl-d-aspartate (NMDA) and cholecystokinin antagonists II-lipophilicity studies on quinazolinones are also documented [11].

    • Synthesis and biological properties of 4-(3H)-quinazolone derivatives

      2007, European Journal of Medicinal Chemistry
      Citation Excerpt :

      Quinazolone and their derivatives are building block for approximately 150 naturally occurring alkaloids isolated from a number of families of the plant kingdom, from microorganisms and animals [1–4] and are now known for a wide range of biological properties including hypnotic, sedative, analgesic, anticonvulsant, antibacterial, antidiabetic, anti-inflammatory, anti-tumor and several other useful and interesting properties [5–13]. In addition, some derivatives are calcium antagonists and share the common property of interfering with the influx of extracellular calcium via the calcium L channel [14]. Recently quinozolone chemistry has got new direction due to some resemblance with folic acid [15–17].

    • Lipids and cardiac arrhythmia

      1994, Progress in Lipid Research
    View all citing articles on Scopus
    View full text